Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FBDIX vs. PBE: which is better?

Bottom line

FBDIX vs PBE: the short answer

FBDIX (Franklin Biotechnology Discovery Fund) and PBE (Invesco Biotechnology & Genome ETF) are both mutual funds.

But FBDIX is far broader, holding 126 positions to 33 for PBE, so beyond the top names it adds exposure PBE doesn't have.

PBE is cheaper at 0.59% vs 1.01% — a difference of $42 a year per $10,000 invested.

Over five years, FBDIX returned +5.0% a year vs +3.4% for PBE.

FBDIX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

FBDIX vs PBE side by side

FBDIXPBE
TypeMutual fundETF
Fund familyFranklin TempletonInvesco
CategoryTechnology SectorTechnology Sector
Expense ratio1.01%0.59%
Annual cost per $10k$101$59
10-yr cost on $10k (prospectus)$1,728$738
Max front load5.5%None
12b-1 fee0.25%—
1-yr return+43.9%+24.7%
5-yr return (annualized)+5.0%+3.4%
10-yr return (annualized)+6.4%+5.2%
Best quarter+29.5%+25.3%
Worst quarter−24.5%−24.3%
Net assets (fund)$1.2B$281.9M
Number of holdings12633
Portfolio turnover38%103%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFBDIXPBEDifference
2025+52.3%+24.7%+27.6%
2024+4.0%+1.1%+2.9%
2023+18.4%+3.7%+14.7%
2022−12.7%−10.8%−1.9%
2021−17.7%+1.6%−19.3%
2020+29.9%+25.5%+4.4%
2019+34.8%+18.3%+16.6%
2018−15.7%+0.2%−16.0%
2017+18.8%+22.4%−3.6%
2016−17.2%−23.0%+5.9%

Source: Fund prospectus bar charts

Holdings overlap

5 of FBDIX's top 25 holdings also appear in PBE's top 25.

Shared top holdings
HoldingFBDIXPBE
Amgen, Inc.4.39%5.22%
Gilead Sciences, Inc.3.86%4.43%
Regeneron Pharmaceuticals, Inc.3.77%5.47%
Vertex Pharmaceuticals, Inc.3.54%4.99%
Neurocrine Biosciences, Inc.1.82%2.66%

Source: SEC Form N-PORT

FBDIX top 10

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Revolution Medicines, Inc. — 3.01%
  9. Guardant Health, Inc. — 2.76%
  10. Ascendis Pharma A/S — 2.56%

PBE top 10

  1. Invesco Private Prime Fund — 12.89%
  2. Regeneron Pharmaceuticals, Inc. — 5.47%
  3. Amgen Inc. — 5.22%
  4. CareDx, Inc. — 5.04%
  5. Vertex Pharmaceuticals Inc. — 4.99%
  6. Invesco Private Government Fund — 4.97%
  7. Royalty Pharma PLC — 4.94%
  8. Biogen Inc. — 4.79%
  9. Gilead Sciences, Inc. — 4.43%
  10. United Therapeutics Corp. — 4.08%

FAQ

What is the difference between FBDIX and PBE?
FBDIX (Franklin Biotechnology Discovery Fund) and PBE (Invesco Biotechnology & Genome ETF) are both mutual funds. But FBDIX is far broader, holding 126 positions to 33 for PBE, so beyond the top names it adds exposure PBE doesn't have.
Which is cheaper, FBDIX or PBE?
PBE has the lower expense ratio (0.59%).
Should I own both FBDIX and PBE?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.